Influence of Publication of US and European Prostate Cancer Screening Trials on PSA Testing Practices

Steven B ZELIADT; Richard M HOFFMAN; Ruth ETZIONI; John L GORE; Larry G KESSLER; Daniel W LIN

doi:10.1093/jnci/djr007

Back

Influence of Publication of US and European Prostate Cancer Screening Trials on PSA Testing Practices

Journal article

Open access

Peer reviewed

Influence of Publication of US and European Prostate Cancer Screening Trials on PSA Testing Practices

Steven B ZELIADT, Richard M HOFFMAN, Ruth ETZIONI, John L GORE, Larry G KESSLER and Daniel W LIN

JNCI : Journal of the National Cancer Institute, Vol.103(6), pp.520-523

2011

DOI: 10.1093/jnci/djr007

PMID: 21357307

Files and links (1)

url

https://doi.org/10.1093/jnci/djr007View

Published (Version of record) Open Access

Abstract

In 2009, results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial indicated no difference in mortality between the screening and the control groups (rate ratio = 1.13, 95% confidence interval = 0.75 to 1.70), whereas those from the European Randomized study of Screening for Prostate Cancer trial indicated a 20% reduction in mortality among the screening group (rate ratio = 0.80, 95% confidence interval = 0.65 to 0.98). In this study, we examined whether prostate-specific antigen (PSA) testing has changed following these publications. The primary outcome measure was the proportion of men seen at least once in a primary care or urology clinic between August 1, 2004, and March 31, 2010, who received a PSA test. Following the publications, PSA use declined slightly-by 3.0 percentage points and 2.7 percentage points among men aged 40-54 and 55-74 years, respectively. PSA testing among men older than 75 years initially declined slightly following the recommendations by the US Preventive Services Task Force in 2008 and continued to decline after the trial publications.

Tumors

Tumors of the urinary system

Urinary tract. Prostate gland

Nephrology. Urinary tract diseases

Biological and medical sciences

Medical sciences

Details

Title: Subtitle: Influence of Publication of US and European Prostate Cancer Screening Trials on PSA Testing Practices
Creators: Steven B ZELIADT - Health Services Research and Development Center of Excellence, VA Puget Sound Health Care System, Seattle, WA, United States
Richard M HOFFMAN - Medicine Service, Department of Veterans Affairs Medical Center, and Department of Medicine, University of New Mexico, Albuquerque, NM, United States
Ruth ETZIONI - Department of Health Services, University of Washington, Seattle, WA, United States
John L GORE - Department of Urology, University of Washington, Seattle, WA, United States
Larry G KESSLER - Department of Health Services, University of Washington, Seattle, WA, United States
Daniel W LIN - Department of Urology, VA Puget Sound Health Care System, Seattle, WA, United States
Resource Type: Journal article
Publication Details: JNCI : Journal of the National Cancer Institute, Vol.103(6), pp.520-523
DOI: 10.1093/jnci/djr007
PMID: 21357307
NLM abbreviation: J Natl Cancer Inst
ISSN: 0027-8874
eISSN: 1460-2105
Publisher: Oxford University Press
Language: English
Date published: 2011
Academic Unit: Epidemiology; General Internal Medicine; Internal Medicine
Record Identifier: 9984094565102771

Metrics

14 Record Views

49 Times Cited - Web of Science